Tumor-Infiltrating Lymphocyte Therapy for Melanoma: Nursing Considerations

被引：0

作者：

Ferguson, Kristin Marie ^{[1
]}

Telfort, Farele ^{[1
]}

Gochett, Celestine G. ^{[2
]}

机构：

[1] MedStar Georgetown Univ Hosp, Washington, DC 20007 USA

[2] Northside Hosp Canc Inst, Atlanta, GA USA

来源：

CLINICAL JOURNAL OF ONCOLOGY NURSING | 2025年 / 29卷 / 02期

关键词：

melanoma; nurse coordination; nurse navigation; cellular therapy; surgery;

D O I：

10.1188/25.CJON.125-129

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Clinicians have used commercially available cellular therapy to treat hematologic malignancies since 2017. In February 2024, the U.S. Food and Drug Administration approved the first commercial cellular therapy-lifileucel, a.

引用

页码：125 / 129

页数：5

共 9 条

[1] High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014
Dutcher, Janice P.
Schwartzentruber, Douglas J.
Kaufman, Howard L.
Agarwala, Sanjiv S.
Tarhini, Ahmad A.
Lowder, James N.
Atkin, Michael B.
[J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2014, 2
[2] Iovance Biotherapeutics, 2024, Powering your treatment with your cells
[3] Iovance Biotherapeutics, 2024, Amtagvi 3-step administration
[4] Lifileucel: FDA-approved T-cell therapy for melanoma
Kwong, Mei Li M.
Yang, James C.
[J]. ONCOLOGIST, 2024, 29 (08) : 648 - 650
[5] Surgical Considerations for Tumor Tissue Procurement to Obtain Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy
Mullinax, John E.
Egger, Michael E.
McCarter, Martin
Monk, Bradley J.
Toloza, Eric M.
Brousseau, Susan
Jagasia, Madan
Sarnaik, Amod
[J]. CANCER JOURNAL, 2022, 28 (04) : 285 - 293
[6] Olsen M., 2023, Chemotherapy and immunotherapy guidelines and recommendations for practice, V2nd ed
[7] Phillips C., 2024, First cancer TIL therapy gets FDA approval for advanced melanoma
[8] U.S. Food and Drug Administration, 2024, Amtagvi
[9] Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy
Warner, Allison Betof
Hamid, Omid
Komanduri, Krishna
Amaria, Rodabe
Butler, Marcus O.
Haanen, John
Nikiforow, Sarah
Puzanov, Igor
Sarnaik, Amod
Bishop, Michael R.
Schoenfeld, Adam J.
[J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (02)

← 1 →